Glenmark Pharmaceuticals Europe Ltd (Glenmark) has announced that it has entered into a strategic development and licensing agreement with Poland based Celon Pharma S.A. (Celon) to develop and market ...

(Reuters) - Vectura Group said on Friday a British court had ruled in its favor on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline. Vectura said the court ...

Asthma UK said that "faulty inhalers could put people's lives at risk" as it called on patients to check whether their inhaler needed to be returned. The call comes after the Medicines and Healthcare ...

Novartis data at ERS 2014 show once-daily Ultibro® Breezhaler® is superior in reducing COPD flare ups compared to Seretide® Once-daily Ultibro® Breezhaler® reduced exacerbations (flare ups) by 31% ...

LONDON & BRISBANE, Calif.--(BUSINESS WIRE)--GlaxoSmithKline plc (LSE/NYSE:GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Commission has approved a label update for the use of ...

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates, clinicians may ...

Novartis has presented data showing that its chronic obstructive pulmonary disease drug Ultibro was superior in reducing flare-ups compared to GlaxoSmithKline’s blockbuster Seretide. Novartis has ...

Oct 4 (Reuters) - Vectura Group said on Friday a British court had ruled in its and partner Sandoz's favour over the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.